Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1260a (miR-1260a) is a small (20–24 nucleotide) non-coding RNA molecule encoded on chromosome 14q24.3. It belongs to the microRNA class and post-transcriptionally modulates gene expression by interacting with a large spectrum of mRNA targets, primarily by inhibiting their translation or destabilizing them[3]. Its abnormal expression has been reported in multiple cancer types, where it has potential utility as a diagnostic and prognostic biomarker due to its ability to interact with oncogenic and tumor-suppressive pathways. In cancer, miR-1260a is associated with upregulation in tumors and correlates with proliferation, invasion, apoptosis, and immune response regulation. It also appears to interact with ribosomal protein family genes, implicating it in translation and tumorigenesis[1][3]. Drugs like Genistein modulate miR-1260b expression, suggesting miR-1260 family members might represent future targets for therapy[1].
Modulation of gene expression via RNA-induced silencing complex (RISC) leading to: - Translational inhibition of target mRNA - Destabilization of target mRNA - Genistein-induced downregulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1260a (miR-1260a).